Literature DB >> 29425491

TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue.

Peng Zhao1, Kai In Wong2, Xiaoli Sun2, Shannon M Reilly1, Maeran Uhm3, Zhongji Liao2, Yuliya Skorobogatko1, Alan R Saltiel4.   

Abstract

The noncanonical IKK family member TANK-binding kinase 1 (TBK1) is activated by pro-inflammatory cytokines, but its role in controlling metabolism remains unclear. Here, we report that the kinase uniquely controls energy metabolism. Tbk1 expression is increased in adipocytes of HFD-fed mice. Adipocyte-specific TBK1 knockout (ATKO) attenuates HFD-induced obesity by increasing energy expenditure; further studies show that TBK1 directly inhibits AMPK to repress respiration and increase energy storage. Conversely, activation of AMPK under catabolic conditions can increase TBK1 activity through phosphorylation, mediated by AMPK's downstream target ULK1. Surprisingly, ATKO also exaggerates adipose tissue inflammation and insulin resistance. TBK1 suppresses inflammation by phosphorylating and inducing the degradation of the IKK kinase NIK, thus attenuating NF-κB activity. Moreover, TBK1 mediates the negative impact of AMPK activity on NF-κB activation. These data implicate a unique role for TBK1 in mediating bidirectional crosstalk between energy sensing and inflammatory signaling pathways in both over- and undernutrition.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; NFκB; cytokine; energy expenditure; insulin resistance; mitochondria; obesity; protein phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 29425491      PMCID: PMC5808582          DOI: 10.1016/j.cell.2018.01.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

Review 1.  The role of AMP-activated protein kinase in mitochondrial biogenesis.

Authors:  Richard M Reznick; Gerald I Shulman
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

Review 2.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

3.  High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and inflammation-related genes.

Authors:  Myung-Sook Choi; Young-Je Kim; Eun-Young Kwon; Jae Young Ryoo; Sang Ryong Kim; Un Ju Jung
Journal:  Br J Nutr       Date:  2015-03-06       Impact factor: 3.718

4.  Reduced rate of energy expenditure as a risk factor for body-weight gain.

Authors:  E Ravussin; S Lillioja; W C Knowler; L Christin; D Freymond; W G Abbott; V Boyce; B V Howard; C Bogardus
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

5.  AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K/p38 MAPK and NF-κB signaling in murine macrophages.

Authors:  Bee-Piao Huang; Chun-Hsiang Lin; Han-Min Chen; Jiun-Tsai Lin; Yi-Fang Cheng; Shao-Hsuan Kao
Journal:  DNA Cell Biol       Date:  2014-12-23       Impact factor: 3.311

6.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1.

Authors:  Joungmok Kim; Mondira Kundu; Benoit Viollet; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-01-23       Impact factor: 28.824

Review 7.  Energy balance and obesity.

Authors:  James O Hill; Holly R Wyatt; John C Peters
Journal:  Circulation       Date:  2012-07-03       Impact factor: 29.690

Review 8.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

9.  Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue.

Authors:  Zhongxiao Wan; Jared Root-McCaig; Laura Castellani; Bruce E Kemp; Gregory R Steinberg; David C Wright
Journal:  Obesity (Silver Spring)       Date:  2013-09-20       Impact factor: 5.002

10.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Authors:  G S Hotamisligil; P Arner; J F Caro; R L Atkinson; B M Spiegelman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  88 in total

1.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Adipose tissue: TBK1 at the crossroad of signalling pathways.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2018-02-23       Impact factor: 43.330

4.  Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor.

Authors:  Douglas W Thomson; Daniel Poeckel; Nico Zinn; Christina Rau; Katrin Strohmer; Anne J Wagner; Alan P Graves; Jessica Perrin; Marcus Bantscheff; Birgit Duempelfeld; Viera Kasparcova; Joshi M Ramanjulu; G Scott Pesiridis; Marcel Muelbaier; Giovanna Bergamini
Journal:  ACS Med Chem Lett       Date:  2019-03-11       Impact factor: 4.345

5.  Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Andrew V Gomez; Louise Chang; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2018-09-20       Impact factor: 3.641

6.  TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation.

Authors:  Jin Young Huh; Shannon M Reilly; Mohammad Abu-Odeh; Anne N Murphy; Sushil K Mahata; Jinyu Zhang; Yoori Cho; Jong Bae Seo; Chao-Wei Hung; Courtney R Green; Christian M Metallo; Alan R Saltiel
Journal:  Cell Metab       Date:  2020-11-04       Impact factor: 27.287

Review 7.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

8.  Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKε and Reveal Mechanisms for Selective Inhibition.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Louise Chang; Andrew V Gomez; Alan R Saltiel; Hollis D Showalter; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2018-08-06       Impact factor: 4.436

9.  An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.

Authors:  Peng Zhao; Xiaoli Sun; Cynthia Chaggan; Zhongji Liao; Kai In Wong; Feng He; Seema Singh; Rohit Loomba; Michael Karin; Joseph L Witztum; Alan R Saltiel
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 10.  From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.

Authors:  Peng Zhao; Alan R Saltiel
Journal:  J Biol Chem       Date:  2020-07-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.